-
Posted by
Two Blokes Tue at 7:45 AM -
Filed in
Stock
-
2 views
Lupin is set to become first Indian company to fully integrate Honeywell's Solstice\u00ae Air in its respiratory inhalers at scale, redefining respiratory care with near-zero global warming potential propellants Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) NEW DELHI and MUMBAI, India , May 20, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) announced today its plan to use Honeywell's Solstice\u00ae Air (HFO-1234ze cGMP) propellant to transform respiratory care through the development of next-generation inhalers. Designed for patients with asthma and chronic obstructive pulmonary disease (COPD), Honeywell Solstice Air has the potential to prevent the release of high global warming potential (GWP) molecules, marking a major step forward in helping to reduce carbon emissions.
